State Street Corp Has $67.69 Million Stock Position in R1 RCM Inc. (NASDAQ:RCM)

State Street Corp decreased its position in R1 RCM Inc. (NASDAQ:RCM) by 11.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,776,631 shares of the healthcare provider’s stock after selling 608,233 shares during the period. State Street Corp’s holdings in R1 RCM were worth $67,685,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Murchinson Ltd. acquired a new position in shares of R1 RCM in the 3rd quarter valued at $184,000. Harvest Management LLC grew its holdings in shares of R1 RCM by 407.2% in the 3rd quarter. Harvest Management LLC now owns 119,700 shares of the healthcare provider’s stock valued at $1,696,000 after buying an additional 96,100 shares during the period. HGC Investment Management Inc. acquired a new position in shares of R1 RCM in the 3rd quarter valued at $432,000. ClearAlpha Technologies LP grew its holdings in shares of R1 RCM by 41.6% in the 3rd quarter. ClearAlpha Technologies LP now owns 105,381 shares of the healthcare provider’s stock valued at $1,493,000 after buying an additional 30,937 shares during the period. Finally, Bardin Hill Management Partners LP lifted its position in R1 RCM by 2.0% in the 3rd quarter. Bardin Hill Management Partners LP now owns 535,939 shares of the healthcare provider’s stock valued at $7,594,000 after acquiring an additional 10,728 shares in the last quarter. Institutional investors and hedge funds own 61.10% of the company’s stock.

R1 RCM Trading Up 0.1 %

Shares of NASDAQ:RCM opened at $14.31 on Wednesday. The company’s 50-day moving average price is $14.28 and its two-hundred day moving average price is $13.70. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.79 and a quick ratio of 1.79. R1 RCM Inc. has a one year low of $8.87 and a one year high of $15.12. The stock has a market capitalization of $6.04 billion, a PE ratio of -95.39 and a beta of 0.84.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings results on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.04). R1 RCM had a negative return on equity of 2.18% and a negative net margin of 2.48%. The business had revenue of $656.80 million for the quarter, compared to the consensus estimate of $640.93 million. R1 RCM’s revenue was up 14.7% on a year-over-year basis. On average, equities analysts forecast that R1 RCM Inc. will post -0.18 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $14.30 price objective on shares of R1 RCM in a research report on Friday, October 4th. Twelve analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $15.73.

R1 RCM Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.